On Monday, Shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), subtract -3.46% and closed at $30.71 in the last trading session. The last trading range of the stock ranges between $30.40 and $31.81. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has accomplished the Phase III pivotal trials for the treatment of Parkinsons disease psychosis and the Phase II trial for the treatment of schizophrenia, in addition to is in Phase II study for the treatment of Alzheimers disease psychosis.
Ecopetrol SA (ADR)(NYSE:EC), dropped -0.80% and closed at $8.69 in the last trading session. The last trading range of the stock ranges between $8.11 and $8.70. The company’s Market capitalization is $17.91 Billion with the total Outstanding Shares of 41.12 Billion. ECOPETROL S.A. (BVC: ECOPETROL; NYSE: EC) informs that it has updated its business plan for the period 2017-2020. This plan seeks to generate value, profitability and sustainability, and prepares the Group to capture the benefits derived from a potential increase in prices. The plan is based on an average price scenario of $50 USD/bl.
The business plan continues to be based upon the main three pillars of the Company’s Corporate Strategy launched in May 2015, i) cash flow focus supported on savings and efficiencies, ii) capital discipline and iii) profitable growth in Upstream.
Cash Flow Focus
As a result of lower oil prices, Ecopetrol has designed strategies aimed at strengthening its cash generation. As A Result, in May 2015, Ecopetrol launched its Transformation Program which, as of recently, has exceeded its projected efficiency and savings aims.
Structurally, Ecopetrol has accomplished a cost reduction of USD 1.100 Million in comparison to 2014. Furthermore, it has divested non-planned assets and has initiated the sale of minor fields through its Fields Round 2016 (Ronda de Campos 2016).
Chimera Investment Corporation (NYSE:CIM), lost -2.51% and closed at $15.55 in the last trading session. The last trading range of the stock ranges between $15.54 and $15.94. During the 52-week trading session the minimum price at which share price traded, registered at $10.89 and reached to max level of $16.98. Chimera Investment Corporation operates as a real estate investment trust in the United States. The company, through its auxiliaries, invests in residential mortgage-backed securities (RMBS), residential mortgage loans, commercial mortgage loans, real estate-related securities, and various other asset classes. The company has elected to be taxed as a real estate investment trust. As a result, it would not be subject to corporate income tax on that portion of its net income that is distributed to shareholders.